Announcement on Voluntary Disclosure of Approval of Marketing Authorization Application for Live Attenuated Nasal-Spray Influenza Vaccine

About this update from Changchun Bcht Biotechnology Co. Class A

Announcement on Voluntary Disclosure of Approval of Marketing Authorization Application for Live Attenuated Nasal-Spray Influenza VaccineThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Changchun Bcht Biotechnology Co. Class A